Castellani to depart PhRMA; group elects Merck's Frazier chairman
This article was originally published in Scrip
Executive Summary
John Castellani plans to step down as CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA) at the end of the year, he disclosed at the mega-drug industry lobbying group's board meeting on 16 April.